Filing Details

Accession Number:
0001477932-20-007402
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-21 08:28:16
Reporting Period:
2020-12-18
Accepted Time:
2020-12-21 08:28:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1643301 Cure Pharmaceutical Holding Corp. CURR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412747 Steven Robert Davidson 1620 Beacon Place
Oxnard CA 93033
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-18 2,300 $1.42 537,769 No 4 P Direct
Common Stock Acquisiton 2020-12-18 2,415 $1.45 540,184 No 4 P Direct
Common Stock Acquisiton 2020-12-18 2,172 $1.44 542,356 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Open market purchases reported on this line occurred at a weighted average price of $1.42 (range $1.415 to $1.430). Mr. Davidson undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
  2. Open market purchases reported on this line occurred at a weighted average price of $1.44 (range $1.425 to $1.460). Mr. Davidson undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.